Table 1.
The Correlation Analysis Between ZFAS1 Expression and Clinicopathological Features of CC Patients
| Clinical Features | ZFAS1 Levels | p value | |
|---|---|---|---|
| High | Low | ||
| Age (years) | |||
| ≤40 | 15 | 19 | 0.332 |
| >40 | 19 | 15 | |
| Size (cm) | |||
| ≥4 | 18 | 15 | 0.467 |
| <4 | 16 | 19 | |
| Differentiation | |||
| Well/moderate | 15 | 18 | 0.467 |
| Poor | 19 | 16 | |
| Papillomavirus (HPV) Infection | |||
| Yes | 20 | 19 | 0.465 |
| No | 14 | 15 | |
| FIGO stage | |||
| I–II | 16 | 25 | 0.026 |
| III–IV | 18 | 9 | |
| Distant metastasis | |||
| Yes | 14 | 4 | 0.006 |
| No | 20 | 30 | |
| Lymph node metastasis | |||
| Yes | 15 | 7 | 0.038 |
| No | 19 | 27 | |
Note: The median value of ZFAS1 in CC tissues was used as cutoff.